Don't listen to them, btcs is a great stock. and most of these bashers are shorting the stock, there just mad its not crashing and instead its about to explode back to the dollar range.
Sentiment: Strong Buy
itellthefuture777, you tell the past very well, also. Al Mann is no ordinary man. Thanks for the facts.
MannKind Long & Strong
Sentiment: Strong Buy
Yeah nobody knows exactly what will happen, but if you don't drill and don't explore, eventually production drops. The lower oil prices go and the less profitable it is to get it out of the ground, the same result occurs. Nobody will continue to produce oil at a loss, so eventually supply is removed.
As everyone has said it is supply issue and not demand. Demand even appears to be increasing, which lead the Saudi's to raise their prices just recently. If it is just the US with oversupply and we are running out of places to store it, then a simple solution is to start exporting oil.
"Some investors are looking to weekly U.S. government inventories data due later on Wednesday to provide more price support, after an industry report showed a smaller-than-expected build-up in U.S. commercial crude stocks last week. [API/S]"
You don't think a move back to 40 would produce huge gains for those that average down ? Nothing is static, moron. BK is not even on the radar, CHK will be a survivor.
90% of the young women will vote for her 40-60% of the older women will vote for her. 20-30% men will vote for her.
I think her time has come and gone. I'll thank her for a-comin and I'm glad she is a-goin. She should be like Romney, step aside now and hope for a V.P. invite.
Provide some proof, Barry. You are making a joke of yourself here. Anyone who trades in or out based on your information, need to get their heads examined.
You will lose all your shorts...
"The effect of Contrave on cardiovascular morbidity and mortality hasn't been established, Orexigen added." The FDA says that because a new study is now required this may delay any potential approval of Contrave for cardiovascular patients. Final study results are expected in 2022 if it begins this year.